More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online ...

Looking for natural alternatives to Ozempic that offer effective and safe weight loss? Many people choose Ozempic for ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...